Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

N1EE Vesicles Promote Liver Metastasis by Inducing EMT and Activating Stellate Cells

ABSTRACT: Nidogen 1-Enriched Extracellular Vesicles Promote Liver Metastasis by Inducing EMT and Activating Stellate Cells

ORGANISM(S): Homo Sapiens

SUBMITTER: Guiyu Wang

PROVIDER: PXD069759 | iProX | Wed Oct 22 00:00:00 BST 2025

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Nidogen 1-Enriched Extracellular Vesicles Promote Liver Metastasis by Inducing EMT and Activating Stellate Cells

Project description:Nidogen 1-Enriched Extracellular Vesicles Promote Liver Metastasis by Inducing EMT and Activating Stellate Cells

2025-08-18 | PXD067442 |

Highly-metastatic colorectal cancer cell released Nidogen 1-Enriched Extracellular Vesicles promote liver metastasis by activating hepatic stellate cells and forming the neutrophilextracellulartraps

Project description:The liver is frequently affected by metastasis in colorectal cancer patients; however, the precise interaction between the liver microenvironment and metastatic colorectal cancer cells remains elusive. Our study reveals that NID1, present in extracellular vesicles (EVs) derived from metastatic colorectal cancer, plays a pivotal role in promoting colorectal cancer liver metastasis (CRLM). EV-NID1 facilitates epithelial-mesenchymal transition (EMT) in colorectal cancer cells by modulating EMT-associated genes. Moreover, EV-NID1 activates hepatic stellate cells (HSCs), which in turn stimulate neutrophil infiltration and induce the formation of neutrophil extracellular traps (NETs) within the hepatic metastatic microenvironment via interleukin 11 (IL-11) secretion. This process ultimately reshapes the tumor microenvironment (TME) and fosters the establishment of a metastatic niche conducive to CRLM. Notably, targeted inhibition of IL-11 signaling using anti-IL-11 monoclonal antibodies effectively suppresses EV-NID1-induced liver metastasis in a murine model. In summary, our findings elucidate the mechanism underlying EV-NID1-mediated regulation of CRLM, presenting a promising therapeutic target for intervention in this disease.

2025-08-01 | GSE263027 | GEO

WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway

Project description:WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway

| PRJNA450652 | ENA

Pancreatic Stellate Cells Promote Growth and Metastasis of Pancreatic Neuroendocrine Tumor

Project description:We aimed to study the interaction of PNETs and pancreatic stellate cells (PSCs) in PNET progression through exploring specific gene expression of PNETs cultured with conditional media of PSCs.

2024-02-22 | GSE167321 | GEO

WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [ChIP-seq]

Project description:WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [ChIP-seq]

| PRJNA450644 | ENA

RNA-seq of METTL4-mediated Nuclear N6-Deoxyadenosine Methylation Promotes Metastasis through Activating Multiple Metastasis-inducing targets

Project description:RNA-seq of METTL4-mediated Nuclear N6-Deoxyadenosine Methylation Promotes Metastasis through Activating Multiple Metastasis-inducing targets

| PRJNA719218 | ENA

ChIP-seq of METTL4-mediated Nuclear N6-Deoxyadenosine Methylation Promotes Metastasis through Activating Multiple Metastasis-inducing targets

Project description:ChIP-seq of METTL4-mediated Nuclear N6-Deoxyadenosine Methylation Promotes Metastasis through Activating Multiple Metastasis-inducing targets

| PRJNA719298 | ENA

WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [ChIP-seq]

Project description:The core subunit of the COMPASS-like complex, WD Repeat Domain 5 (WDR5) has a prominent role in reprogramming and Epithelial-to-Mesenchymal transition (EMT) in different tumor types. Our evidences support a model in which WDR5 is prominent for EMT and metastasis dissemination in breast cancer patient-derived xenografts and cell lines. Moreover, WDR5 silencing abrogates TGFB pathway activation and reverts mesenchymal into epithelial phenotype, by inhibiting transcription of main master regulators of EMT (CDH2, TWIST1, SNAI1, SNAI2 and ZEB1). Our data suggest that WDR5 inhibition may be a successful approach to prevent progression of metastatic BC.

2019-12-17 | GSE113279 | GEO

WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [RNA-seq PDX]

Project description:WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [RNA-seq PDX]

| PRJNA450653 | ENA

WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [RNA-seq CCL]

Project description:WDR5 regulates EMT and metastasis in breast cancer by activating TGFB pathway [RNA-seq CCL]

| PRJNA450647 | ENA